The single-nucleotide polymorphism variants of MAO-A were significantly related to patients with oral and pharyngeal cancers in comparison to patients with OPMD (risk G-allele for rs5953210, OR = 1.76; 95% CI = 1.02–3.01) [145]. This evidence concerns the gene MAOA and pharynx cancer.